Zobrazeno 1 - 10
of 120
pro vyhledávání: '"R Ujhelyi"'
Autor:
Michael R. Ujhelyi
Publikováno v:
Pharmacotherapy. 28:1311-1314
Autor:
Michael V. Orlov, Peter Hoffmeister, Gregory Kotler, Michael R. Ujhelyi, Gunjan Shukla, Charles I. Haffajee, Susan Mcallister, G. Muqtada Chaudhry, Ibrahim Almasry, Michael Maysky, Spyridon T. Akrivakis
Publikováno v:
Journal of Interventional Cardiac Electrophysiology. 23:127-133
We prospectively determined whether preimplant myocardial perfusion imaging (MPI) predicts outcome with biventricular pacing (BiVP).Single-photon emission computed tomography (SPECT) MPI, left ventricular (LV) volumes, ejection fraction (EF), 6-min h
Publikováno v:
The Journal of Vascular Access. 9:20-27
Background Catheter failure, either due to dislodgment, occlusion or infection is the leading complication of chronic intravenous drug therapy. Better drug delivery techniques are required to advance life saving therapies that require this delivery m
Autor:
Jie Cheng, James A. Coles, Michael R. Ujhelyi, Vadim Levin, Margit Nemeth, Abdi Rasekh, Mehdi Razavi, Ali Massumi, Ilyas Colombowala
Publikováno v:
Journal of Cardiovascular Electrophysiology. 18:290-295
Background: Optimizing atrioventricular (AV) delay during biventricular (BiV) pacemaker implantation can require substantial resources. Hence, a simpler method is desirable. We hypothesized that interatrial conduction time (IACT), measured at the tim
Autor:
David Schwartzman, Michael R. Ujhelyi, Tanya J. Fabian, Sharon E. Corey, Patricia D. Kroboth, Bruce G. Pollock, Kristin L. Bigos
Publikováno v:
Journal of Cardiovascular Electrophysiology. 17:391-395
Decreasing Pain and Anxiety Associated with Atrial Shock. introduction: Implantable atrial defibrillators (IADs) have proved to be safe and effective in the management of atrial fibrillation. A potential limitation of self-activated IAD therapy is pa
Autor:
Luis G. Alvarez, Robert H. Hoyt, Eva R. Serber, Michael R. Ujhelyi, Samuel F. Sears, David Schwartzman
Publikováno v:
Pacing and Clinical Electrophysiology. 28:801-807
Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with a variety of symptoms such as dizziness, palpitations, shortness of breath, and other signs of heart failure, which in turn impact quality of life (QOL)
Autor:
Xiaohong Zhou, John M. Miller, Michael R. Ujhelyi, William J. Groh, Deepak Bhakta, Josh Rosenberger, Douglas P. Zipes, Ziad F. Issa
Publikováno v:
Circulation. 111:3217-3220
Background— Thoracic spinal cord stimulation (SCS) is a promising therapy in treating refractory angina. This study was designed to investigate SCS with regard to the risk of arrhythmias during myocardial ischemia and its cardiac electrophysiologic
Publikováno v:
Pacing and Clinical Electrophysiology. 27:910-917
Acceptability of the atrial defibrillator is partly limited by concerns about shock related anxiety and discomfort. Sedation and/or automatic cardioversion therapy during sleep may ease shock discomfort and improve patient acceptability. Three atrial
Publikováno v:
Cardiovascular Drugs and Therapy. 18:269-277
Purpose: The hypothesis that intrapericardial (ip.) ibutilide administration would terminate pacing-induced sustained atrial fibrillation (AF) and ibutilide distribution were tested. Methods and results: Sustained (≥24 hours) AF was induced by 59
Autor:
David Schwartzman, Luis G. Alvarez, Jason L. Burns, Michael R. Ujhelyi, Robert H. Hoyt, Rebecca O. Sotile, Samuel F. Sears
Publikováno v:
Journal of Cardiovascular Electrophysiology. 15:286-291
Introduction: The Medtronic Jewel AF 7250 is an implantable cardioverter defibrillator with atrial and ventricular therapies (ICD-AT). The ICD-AT is effective in managing atrial tachyarrhythmias (atrial fibrillation [AF]), but patient acceptance rema